The Iranian headquarters dedicated to the development of traditional medicine and medicinal herbs has proposed establishing a trilateral consortium named Abu Ali Sina (Avicenna). This consortium will be created in cooperation with Tajikistan and Afghanistan to stimulate scientific, technical, and innovative interaction in the field of healthcare.
Hossein Rezaizadeh, head of this headquarters, emphasized the necessity of utilizing Avicenna's scientific and pharmacological heritage to expand regional scientific and technical cooperation, citing the common scientific, cultural, and historical opportunities of the three countries. He made these statements during the International Scientific Conference titled 'Abu Ali Sina and His Contribution to Shaping a New Scientific Worldview,' which took place in Geneva at the Palais des Nations on November 12.
The initiative aims to lay the foundation for targeted regional cooperation in healthcare, transforming shared scientific and historical ties into technological achievements. This will be achieved by leveraging the potential of universities, research centers, and knowledge-based companies in Iran, Tajikistan, and Afghanistan.
Key areas of the proposal include expanding joint research, documenting and re-examining medical and pharmacological sources, standardizing natural products, and strengthening cooperation in utilizing the potential of medicinal plants.
The proposed 'Avicenna Consortium for Science, Health, and Innovation' could serve as a common platform for organizing the scientific capabilities of the three nations, developing joint projects and programs in the healthcare sector, especially in traditional medicine, medicinal plants, and pharmacological heritage.
To implement this proposal, Rezaizadeh suggested forming a working group that would develop a three-year action plan to clarify priorities, the course of cooperation, and the implementation of a flagship joint project in the field of medicinal plants and pharmacological heritage.
The International Scientific Conference gathered representatives from diplomatic corps, international organizations, academic and research institutions, as well as distinguished scientists and researchers. Participants discussed Avicenna's significant contribution to the development of world science and philosophy, the importance of his scientific and intellectual legacy, and the role of his humanistic ideas in promoting dialogue between East and West.
Special attention was paid to preserving, studying, digitizing, and promoting Ibn Sina's scientific heritage, strengthening international scientific cooperation, and advancing the universal values of knowledge, enlightenment, rational inquiry, and intercultural understanding.
Addressing the event, the Iranian Ambassador and Permanent Representative to Geneva, Ali Bahreini, stated: 'Today the world is fighting against egocentrism, extremism, and division, and needs wisdom, scientific curiosity, and freedom from prejudice more than ever.' He noted that Avicenna, drawing upon Persian, Greek, and Indian intellectual traditions, opened new horizons in understanding humanity and the world. Bahreini added that his greatness lies not only in his scientific achievements but also in his open mind, intellectual humility, and commitment to truth and humanity. He concluded: 'Avicenna belongs to all ages. He is a bridge between East and West and a reminder that the highest form of power is the power of thought put into service of humanity.'
Persian Medicine
Persian medicine, one of the oldest systems of traditional medicine in the world, has a long history of scholarship associated with prominent physicians such as Razi and Avicenna. Its traditional structure places great emphasis on maintaining health, preventing diseases, and adopting appropriate lifestyles.
According to data previously published by the Ministry of Health, the country ranks third globally in the number of registered clinical trials in traditional medicine on the World Health Organization's International Clinical Trials Registry Platform (ICTRP), trailing China and India. The share of clinical trials in traditional and complementary medicine in Iran accounts for about three percent of all clinical trials registered in the country, while only about 0.3 percent of medical personnel are experts in this field. This report demonstrates the high potential of Iranian researchers in the direction of evidence-based medicine.
Persian traditional medicine strongly focuses on prioritizing health preservation and disease prevention over treatment. It is one of the most ancient forms of traditional medicine and is based on the concept of four humors: phlegm (Balgham), blood (Dam), yellow bile (Safrā’), and black bile (Sawda’). The concept of four humors is based on the teachings of Razi and Avicenna within a complex medical system.
Currently, approximately 30,000 plant species have been identified worldwide, of which Iran accounts for about 8,000 species, exceeding the total number of species found in Europe. About 500 experts provide medical and health services across the country, and over 1,000 general practitioners who have completed courses approved by the Ministry of Health also provide services.
Training experts in Persian medicine has always been a focus of the Ministry of Health. Therefore, various advanced training courses have been developed and conducted under its leadership.



